GALP(3-32) (human)



GALP(3-32) (human)

A1AA1H2HH2R3RR3G4GG4R5RR5G6GG6G7GG7W8WW8T9TT9L10LL10N11NN11S12SS12A13AA13G14GG14Y15YY15L16LL16L17LL17G18GG18P19PP19V20VV20L21LL21H22HH22L23LL23P24PP24Q25QQ25M26MM26G27GG27D28DD28Q29QQ29D30DD30

SMILES None
InChIKey XKXOALDYCBSJGJ-VGPQRCSDSA-N
Sequence AHRGRGGWTLNSAGYLLGPVLHLPQMGDQD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

GALP(3-32) (human)

A1AA1H2HH2R3RR3G4GG4R5RR5G6GG6G7GG7W8WW8T9TT9L10LL10N11NN11S12SS12A13AA13G14GG14Y15YY15L16LL16L17LL17G18GG18P19PP19V20VV20L21LL21H22HH22L23LL23P24PP24Q25QQ25M26MM26G27GG27D28DD28Q29QQ29D30DD30

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.